NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx Pharmaceutical (RARE) Remains Unprofitable, but 28.5% Revenue Growth Strengthens Bullish Narratives

Ultragenyx Pharmaceutical (RARE) continues to operate at a loss, with net losses growing at a rate of 14.8% per year over the past five years and no improvement in profit margins. Despite these persistent losses, revenue is forecast to climb 28.5% per year and earnings are set to jump 81.24% annually, with expectations for RARE to reach profitability within three years. The stock is trading at $31.87, notably below its estimated fair value of $361.43, positioning it as potentially undervalued...
NYSE:CWEN.A
NYSE:CWEN.ARenewable Energy

Clearway Energy (CWEN.A) Margin Falls to 5.3%, Undercuts Bullish Profit Growth Narratives

Clearway Energy (CWEN.A) posted a net profit margin of 5.3%, a decline from last year’s 7.2%. Average earnings growth over the past five years has been just 1.2% per year, but the most recent results show negative year-over-year earnings growth. Looking ahead, earnings are forecast to grow at an impressive 23.1% annually, which is well ahead of the US market average. Revenue is expected to rise 9.6% per year, slightly lagging the broader market. Investors face mixed signals as the stock...
NYSE:EVC
NYSE:EVCMedia

Entravision (EVC) Losses Worsen, Undermining Market Optimism on Profit Turnaround

Entravision Communications (EVC) continues to struggle with profitability, posting net losses that have widened over the past five years at an annual rate of 69.7%. The company’s net profit margin shows no sign of improvement while it remains unprofitable, and recent earnings trends do not offer any evidence that profit growth has picked up. The data highlights mounting risks for investors, with high and rising losses overshadowing any potential rewards at this stage. See our full analysis...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Flywire (FLYW) Swings to Profitability, One-Off Loss Tests Bullish Narratives

Flywire (FLYW) has posted a sharp turnaround, swinging to profitability with net profit margins improving over the last year and earnings growing at an impressive 40.3% per year for the past five years. While the company registered a sizable one-off loss of $6.5 million for the twelve months ending September 30, 2025, revenue is projected to increase at 13.7% per year and earnings are forecast to soar 68.1% per year, both comfortably ahead of US market averages. These trends highlight a...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Vertex Pharmaceuticals (VRTX): Profit Margins Improve, But Revenue Growth Lags Market Into Earnings Season

Vertex Pharmaceuticals (VRTX) is forecasting revenue growth of 8.8% annually, trailing the broader US market’s 10.5% pace. Earnings are expected to rise 13.3% per year, slower than the US average of 16%. Over the past five years, the company’s earnings have actually declined by 10.4% per year, yet Vertex recently moved into profitability and has improved its net profit margins. This puts a spotlight on ongoing improvements in earnings quality this season. See our full analysis for Vertex...
NYSE:JXN
NYSE:JXNDiversified Financial

Jackson Financial (JXN): Profitability Turnaround Forecast Reinforces Bullish Valuation Narrative

Jackson Financial (JXN) posted a net loss, with losses having deepened at a rate of 14.3% per year over the past five years. Looking ahead, analysts project revenue growth of 2.4% per year and earnings growth of 5.68% annually, with JXN expected to reach profitability within the next three years. For investors, these figures signal that the current unprofitability may be a temporary challenge. A turnaround could be on the horizon as earnings are forecast to improve. See our full analysis for...
NYSE:VVX
NYSE:VVXAerospace & Defense

V2X (VVX) Earnings Soar 798%—Profit Margin Breakout Reinforces Bullish Valuation Narrative

V2X (VVX) delivered a breakout year on the bottom line, with net profit margins climbing to 1.8% from just 0.2% last year. Although earnings had trended down over the last five years (declining 4.9% per year), the most recent year saw an astonishing 798.1% earnings growth. Investors will note that while revenue is expected to grow at a more modest 4.3% annually, VVX's solid price-to-earnings ratio and strengthening margins highlight a sharp turnaround in profitability. See our full analysis...
NYSE:XIFR
NYSE:XIFRRenewable Energy

XPLR Infrastructure (XIFR): Deepening Losses Challenge Bullish Turnaround Narrative Despite Low Valuation

XPLR Infrastructure (XIFR) saw losses deepen at an average rate of 44% per year over the past five years, with no improvement in its net profit margin and no record of high-quality earnings. Revenue is projected to grow 3% annually, which is notably slower than the broader US market’s 10.5% expected annual pace. However, earnings are forecast to rise at a robust 38.82% per year, and the company is expected to reach profitability within three years. Investors have a clear catalyst to watch...
NYSE:ES
NYSE:ESElectric Utilities

Eversource Energy (ES): Return to Profitability Complicates Bearish Narratives on Earnings Quality

Eversource Energy (ES) posted a nuanced set of financial results as reported in its latest filings. Over the past five years, earnings have declined at an average rate of 24.8% per year. However, the company managed to return to profitability in the most recent year, aided by the effects of a non-recurring $764.7 million loss that weighed on the quality of reported EPS. While revenue is forecast to grow at 5.3% per year and annual earnings growth is estimated at 6.13%, both figures trail the...
NasdaqGS:ALGT
NasdaqGS:ALGTAirlines

Allegiant Travel (ALGT): Losses Worsen but Earnings Forecast to Jump 99.56% Annually

Allegiant Travel (ALGT) remains in the red, posting losses that have deepened at an average rate of 19.8% per year over the past five years, with no improvement in its net profit margin over the last year. Even so, analysts are calling for a dramatic turnaround, forecasting earnings growth of 99.56% per year and expecting the company to become profitable within three years. This pace outstrips average market growth. Revenue, meanwhile, is expected to rise 5.3% per year. See our full analysis...
NYSE:NGL
NYSE:NGLOil and Gas

NGL Energy Partners (NGL): Losses Narrow 36% Annually, Market Price Far Exceeds DCF Value

NGL Energy Partners (NGL) remains unprofitable, with no available forecasts for earnings or revenue growth. However, it has managed to narrow its losses by 36% annually over the past five years. Despite the absence of earnings, NGL’s Price-to-Sales ratio of 0.3x is notably below both the US Oil and Gas industry average of 1.5x and the peer average of 1.1x. This indicates the stock is valued attractively on its sales multiples. The market price of $8.57 currently sits above the $2.71 fair...
NYSE:CRGY
NYSE:CRGYOil and Gas

Crescent Energy (CRGY): $38.5M One-Off Loss Pressures Margins, Challenging Earnings Growth Narrative

Crescent Energy (CRGY) is forecasting exceptionally strong earnings growth of 58% per year, leaving the US market’s 16% growth prediction far behind. However, revenue is only expected to rise at 8.9% annually, trailing the broader market’s 10.5% pace. Net profit margin has dropped to 0.7% from 2.2% last year after a one-off $38.5 million loss took a bite out of profitability. The numbers set up a compelling mix of robust future earnings potential, offset by real concerns about recent margin...
NYSE:SQM
NYSE:SQMChemicals

Is SQM Fairly Priced After a 32% Rise and Ongoing Lithium Market News?

Curious if Sociedad Química y Minera de Chile’s shares are a bargain right now? You’re not alone in wondering whether this is a can’t-miss value play or a stock to watch from the sidelines. Lately, the stock has seen some major momentum, jumping 10.2% over the last month and notching a remarkable 32.0% gain year-to-date, although longer-term returns remain in the red over three years. Recent news continues to put SQM into the spotlight, with analysts and investors weighing both opportunities...
NasdaqGS:DAWN
NasdaqGS:DAWNBiotechs

Day One Biopharmaceuticals (DAWN): Fastest Projected Revenue Growth Challenges Undervaluation Narrative Ahead of Earnings

Day One Biopharmaceuticals (DAWN) is still reporting losses, but over the past five years, the company has steadily narrowed those losses at a rate of 0.1% per year. With future revenue expected to climb 30.6% annually and earnings forecast to rise a substantial 86.63% per year, DAWN is projected to become profitable within three years. This pace stands out compared to the broader US market. Investors will likely see this combination of robust growth expectations and a share price trading...
NasdaqGS:PCTY
NasdaqGS:PCTYProfessional Services

Paylocity (PCTY): Margin Moderation Challenges Bull Case as Profit Growth Slows vs. History

Paylocity Holding (PCTY) is forecasting earnings growth of 14.2% per year and revenue growth of 8.8% per year, both slightly below the US market averages of 16% and 10.5%, respectively. The company’s net profit margin narrowed a bit to 14.2% from last year’s 14.7%, while recent annual earnings growth of 9.8% falls well short of its five-year average pace of 30.1% per year. These results together show a moderation in profit momentum even as Paylocity continues to be recognized for delivering...
NasdaqGS:CLNE
NasdaqGS:CLNEOil and Gas

Clean Energy Fuels (CLNE): Losses Worsen With 30.5% Annual Increase, Undermining Bullish Valuation Narratives

Clean Energy Fuels (CLNE) remains unprofitable, with losses growing at an annual rate of 30.5% over the past five years. The outlook calls for continued losses for at least the next three years. Revenue is expected to grow at 7.9% per year, but this is notably slower than the 10.5% yearly growth projected for the broader US market. Despite trading below estimated fair value, the company's persistent negative net profit margin continues to weigh on sentiment. See our full analysis for Clean...
NYSE:ATEN
NYSE:ATENSoftware

A10 Networks (ATEN): Earnings Growth Beats Five-Year Trend, Reinforcing Margin Optimism

A10 Networks (ATEN) delivered earnings growth of 17% over the past year, outpacing its five-year average of 2.5% per year, with net profit margins improving to 18.5% from 17.5% last year. Looking ahead, earnings are forecast to grow 19.7% annually, topping the expected US market rate of 16% and the company’s own revenue growth outlook of 7% per year, which lags the broader market pace of 10.5%. With high-quality earnings and shares trading at a 25.5x price-to-earnings ratio, which is below...
NasdaqGS:INTA
NasdaqGS:INTASoftware

Intapp (INTA) Revenue Growth Forecast Tops Market as Unprofitability Challenges Valuation Narrative

Intapp (INTA) remains unprofitable, but revenue is forecast to grow 12.3% per year. This growth rate tops the US market average of 10.5% annual growth. Over the last five years, the company has managed to cut its losses by 19.4% annually. However, there is not enough detail available to judge improvements in net profit margin or expected earnings growth. As investors weigh the company’s strong revenue trajectory against ongoing unprofitability, the long-term reward appears to depend on...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Cirrus Logic (CRUS) Profit Margins Expand, Reinforcing Bullish Narrative on Earnings Quality

Cirrus Logic (CRUS) reported net profit margins of 18.1%, up from 16.3% a year ago, highlighting further expansion in profitability. Earnings grew 16.4% from the previous year, well above the company's five-year average annual growth rate of 7.7%. With margins on the rise and profit momentum solid, investors are likely viewing these results as a sign of high-quality earnings, even as future earnings and revenue growth are expected to slow compared to broader US market averages. See our full...
NYSE:RVLV
NYSE:RVLVSpecialty Retail

Revolve Group (RVLV) Earnings Growth Rebounds, Premium Valuation Raises Expectations vs Market Narratives

Revolve Group (RVLV) posted revenue growth of 7% per year, trailing the US market’s expected 10.5% pace. EPS rose in line with a sharp earnings turnaround, up 37.6% from last year and reversing the company’s five-year average annual decline of 17.1%. Net profit margins climbed to 3.8%, compared to 3.1% a year ago, and earnings are projected to grow 15% annually, just shy of the US market’s 16% forecast. As shares trade above fair value at $22.18 and the Price-To-Earnings ratio stands at...
OTCPK:RVRF
OTCPK:RVRFBanks

River Financial (RVRF) Net Margin Surges to 32.9%, Reinforcing Bullish Value Narratives

River Financial (RVRF) posted net profit margins of 32.9%, up from last year's 28.5%, with EPS growth for the past year coming in at 39.9%. The company’s strong momentum continues to show through a five-year annual earnings growth rate of 11.9% and high-quality profits that support these headline numbers. Investors looking for value may take notice, as shares trade at just 7x earnings, well below both the US Banks industry average of 11x and estimated fair value of $67.91, with the stock...
NasdaqGS:MASI
NasdaqGS:MASIMedical Equipment

Masimo (MASI): Losses Rise 53% Annually, Profitability Turnaround in Focus vs Bearish Narratives

Masimo (MASI) remains unprofitable, with losses growing at an annualized rate of 53.1% over the past five years. Looking ahead, earnings are expected to climb 12.03% per year with a return to profitability forecast within three years, outpacing average market growth. The stock trades at $142.14, which is below its estimated fair value of $157.06. Revenue is projected to grow at 6.5% per year, which is slower than the broader US market's 10.5% pace. See our full analysis for Masimo. Next,...
NasdaqCM:MARA
NasdaqCM:MARASoftware

MARA Holdings (MARA) Margin Gains Challenge Bearish Narratives Despite Forecasted Earnings Decline

MARA Holdings (MARA) reported net profit margins of 27.5%, higher than last year, as earnings grew by 463.2% in the most recent year and have increased at a 39.9% annual rate over the past five years. The stock is currently trading at $17.13, sitting well below its estimated fair value of $23.32, with a price-to-earnings ratio of 6.6x that stands out against the software industry average. While revenue is forecast to grow 13.1% per year, outpacing the US market, investors are weighing this...
NasdaqGS:SHOP
NasdaqGS:SHOPIT

Shopify (SHOP) One-Off $582M Gain Clouds Margin Quality, Challenges Growth Sustainability Narratives

Shopify (SHOP) posted forecast-beating numbers with earnings expected to grow 20.53% per year and annual profit growth of 20.5%, while revenue is anticipated to climb 18.5%. Both figures surpass US market averages of 16% for earnings and 10.5% for revenue. The company’s net profit margin edged slightly lower to 16.7% from 16.8% last year, and results were recently buoyed by a one-off $582 million gain in the twelve months to September 30, 2025. Investors are likely scrutinizing whether...